Monday, May 26, 2014

NevBio to have President of Roseman University of Health Sciences, Renee Coffman, speak on the Roseman Teaching Method

Dr. Renee Coffman, President of Roseman University of Health Sciences, will speak on Tuesday, May 20, 2014 on the the "Roseman Method",

The Roseman Method is an innovative teaching method:
1. Block Curriculum. Each class is an immersion into the topic with one course at a time, six hours a day for five days a week, which allows students to completely focus on that topic to gain a deeper understanding.
2. Content Mastery. Roseman does not have grades. Students either pass or fail. To pass the students must achieve 90% on all tests.
3. Variety of Teaching Methods. Roseman understands that students learn the material in different ways which is why they employ several methods of teaching - lecture, hands-on, experimental and real-life situations.
4. Collaboration. Students must work together as part of the learning process. Because students are not graded, there is no competition between students. Students feel free to help other. It's a positive environment.

"When You Build a University from Scratch, You are Free to Invent and Improve on the Status Quo."

The results are impressive. Roseman students in Pharmacy, Nursing and Dental Medicine consistently pass 95% on their first time on their examination boards.

Dr. Renee Coffman is the president and co-founder of Roseman University which offers Colleges of Pharmacy, Nursing and Dental Medicine, an MBA program and has more than 1,000 students. She holds a pharmacy degree from Ohio Northern University and her doctorate is in industrial and physical pharmacy from Purdue University.

Dr. Coffman's mentor is co-founder, Dr. Harry Rosenberg. He taught her that whether it's a student in a classroom or an employee, no one walks in hoping to fail. "Your main focus is really simple-it's to help that individual succeed. I strive every day to ensure that my students can succeed in the classroom and that people who work for Roseman have opportunity to succeed in their jobs," she told the Las Vegas Woman Magazine, May 2013.

Sunday, May 4, 2014

City of Las Vegas to Talk About $1 Million Grant for Contest for Best Idea for Las Vegas on April 30, 2014

The City of Las Vegas launches Strong Cities, Strong Communities Challenge: $900,000 of cash prizes available for effective solutions to help grow the local economy.

The Strong Cities, Strong Communities (SC2) Challenge is a prestigious international competition that will award $900,000 in prizes for the most innovative, creative & transformational economic development plans to help revitalize targeted areas within the city. 

The SC2 Challenge is federally funded by a $1 million grant from the U.S. Department of Commerce's Economic Development Administration (EDA). It was awarded in 2012 to three U.S. cities:  Las Vegas, Nevada; Greensboro, North Carolina; and Hartford, Connecticut.

The goal of the competition is to assist participating cities, including Las Vegas, in cultivating well-conceived, innovative ideas to revitalize four targeted areas within the community:  Cashman Center, the Las Vegas Medical District, business parks, and existing Redevelopment projects.

Bill Arent is the Director of Economic & Urban Development Department for the the City of Las Vegas. The Office creates, coordinates and encourages new development and redevelopment in Las Vegas, with an emphasis on the downtown area. It strives to increase and diversify the city's economic base through business attraction, retention and expansion programs. He was promoted to this position in October 2009. Employed with the city since 1997, Arent has held numerous positions in housing development, economic development and redevelopment. He was the senior project manager for Symphony Park, and has negotiated development agreements for the Cleveland Clinic Lou Ruvo Center for Brain Health and The Smith Center for the Performing Arts. 
Arent holds a Bachelor of Arts in Economics from the University of Pennsylvania and a Master of Public Administration from the University of Nevada, Las Vegas. He is certified as an economic development finance professional.

Medical Marijuana: Talk by Tick Segerblom & Bio-Chemistry by UNLV Scientist, Martin Schiller on March 26, 2014

Richard "Tick" Segerblom is a Nevada State Senator. He was first elected to the Nevada Assembly in 2006. He was elected to the Nevada State Senate in 2012 to represent Senate District 3. He is a fourth generation Nevada representative. His mother, Gene Segerblom (née Wines), served in the Nevada Assembly from 1992 through 2000 and was a member of the Boulder City Council. His grandmother, Hazel Wines (née Bell), served in the Nevada Assembly from 1934 - 1936 representing Humboldt County. Segerblom's great-grandfather was William "Johnny" Bell representing Humboldt County from 1906 to 1914 in the Nevada Senate. Segerblom was Chairman of the Nevada Democratic Party from 1990 to 1994.
Segerblom represents Senate District 3 which encompasses a portion of urban Clark County including portions of the City of Las Vegas. 
Tick is also a practicing attorney.

Nevada Set to Make Millions on Medical Marijuana
According to an article in the Las Vegas Review-Journal last July, Tick Segerblom told a group that pot dispensary owners in Nevada are in a perfect position to make millions of dollars because the state is the only one in the country that plans to accept out-of-state medical marijuana cards.
State Senator Tick Segerblom helped pass the law (3) that helped legalize the dispensaries. As reported, Tick believes that the medical marijuana business to be a boon not only for state coffers but also for the 40 operators who will be able to sell medical pot to anybody who holds a card from another state.

At last tally 19 states had legalized medical marijuana - from Colorado to Oregon and Washington to Connecticut, Vermont and Delaware.

Tick went on to say that "...with the millions of people who visit here, I don't need to tell you how profitable it can be. And Nevada needs the money. It's very short on revenue. But we're not going to become a Venice Beach. Nevada has a thorough and fair bill, and we're going to regulate this industry the right way." 

NevBio to host Zach Miles, Esq., the New Director of Tech Transfer at UNLV on February 26, 2014

Zach Miles, Esq. was hired in November 2013 as the Executive Director of UNLV Technology Transfer and Development. His job is to manage the commercialization of intellectual property owned by UNLV. Prior to UNLV, Miles worked with the Tech Venture & Commercialization at the University of Utah where he helped numerous startups. 

He was the Deputy Executive Director when University of Utah was named the top university in the country for creating startup companies (something needed in Southern Nevada) by the Association of University Technology Managers, beating out schools such as MIT, Johns Hopkins and Purdue.

He has a BS in Microbiology from Weber State University and a JD from the University of New Hampshire School of Law.

NevBio's Deans' Talk & Legislator Luncheon on January 21, 2014

NevBio is sponsoring our first "Deans' Talk" with two science deans. They will talk about the increasing demand for science education for careers in medicine and research:
* How is Southern Nevada meeting this demand?
* What are the accomplishments?
* How do we prepare for Southern Nevada's medical & biomedical future?

Timothy L. Porter, PhD. was hired as the Dean of the UNLV College of Sciences. He was a professor of physics and astronomy at Northern Arizona University.  He served as the director of the university's Growing Biotechnology Initiative. He holds five U.S. patents for the development of specialized sensors. Prior to his time at NAU, Porter served as a research associate at Arizona State University and as a staff physicist for the Hughes Aircraft Company.
Porter earned a Ph.D. in physics from Arizona State University in 1988. He received M.S. and B.S. degrees in physics from California State University.

Andy Kuniyuki, PhDcurrently serves as the Dean of Liberal Arts and Sciences at Nevada State College. He received his B.S. in biology from the University of Hawaii and his Ph.D. in genetics from the University of California. Dr. Kuniyuki's belief that Biology is preeminent began with his study of the Hawaiian Drosophila and continued with his many research endeavors employing monoclonal antibody, tissue culture, oligonucleotide and immunodiagnostic technologies. 

Dr. Kuniyuki's passion for teaching took him deep within the cellblocks of San Quentin Prison where he taught genetics to a captured audience while completing his doctorate at Berkeley. 

NevBio Welcomes Trevor Dardik, CEO & Founder of UniTsem at December 12, 2013 Luncehon

Trevor was invited by the Downtown Project to stay at Tony Hsieh's crash pad. The crash pad is a set of condos for important visitors such as entrepreneurs, company founders & CEOs. 

Trevor Dardik is the CEO & Co-founder of UniTsem. He was the president of LifeWaves International LLC for five years.  LifeWaves monitors 11 different bioindicators to understand how the body responds to exercise. It uses the HeartWave Cycles Exercise® Program and state-of-the-art Rhythmic Biofeedback system to improve one's health. 
Trevor has a BAIS in Biology from Fairleigh Dickinson University in Hackensack, NJ and was a former professional track athlete.

Trevor will talk about the wearable EKG monitor that his company is delivering along with other medical devices products his Italian company is selling in Europe.

NevBio and CEO-CFO International Hosts Delegation from Kazakhstan on Nov 20, 21 & 22, 2013

NevBio and the CEO-CFO Group International hosted of delegation of professors, governmental officials and businessmen for three days of classes at the Mansion formerly owned by Mike Tyson which is now owned by Equiinet International.

During the three days, the delegation attended classes and tours of businesses. Speakers included Richard Helfrich who spoke on creating innovation in the United States and other countries. Steve Curtis spoke on Unmanned Aerial Vehicles in Nevada and its future in the world. Dr. Oliver Hemmers spoke on common challenges that Kazakhstan and Nevada face. Zane Wilson, CEO of GMIS spoke about the medical isotope industry. Leith Martin, CEO of Equiinet spoke about small business innovation and their company's product which is one box to handle voice, internet, security and backup. Matthew Waymire talked about how Americans "tinker" and develop new products - new products that came out of garages such as Apple, Hewlett Packard and others. Kent Rippy talk about marketing and social media. Former Congresswoman Shelley Berkley spoke about her relationship with Kazakhstan and how she helped the US work closer with Kazakhstan.

Trips were taken to the University of Nevada of Las Vegas (UNLV) College of Sciences, UNLV Gaming Institute and UNLV College of Engineering. The delegation visited with Dr.Andy Kunuki at Nevada State College where they discussed new teaching methods. The group toured the Atomic Testing Museum. Kazakhstan also hosted USSR's nuclear testing site.

Wednesday, April 30, 2014

NevBio to Join the SciTech Showcase & Dinner on October 24, 2013

Last Day to Buy Tickets:  SciTech Showcase & Dinner on Oct 24, 2013 in Las Vegas at the World Market Center


Nancy Phillips, CEO of ViaWest
One of the Largest Privately Owned Data-Center Companies in the Nation  
Darik Volpa, CEO of
Named "Most Inspiring" by PharmaVOICE
Thursday, October 24, 2013
4 pm Showcase & Cocktails
6 pm Dinner & Program
World Market Center
RSVP here
Last day to buy tickets (Oct 15th)

Don't Miss the Exhibitors: 
NevBio, Actus Biotechnologies, BridgeBank, 
BNY Mellon, Brennan Capital Partners, 
Bruce & Banka CPAs, The City of Henderson, 
City National Bank, Cleveland Clinic, CorCell, 
Equon Pharmaceuticals, Inc., Hamilton Lane, 
Howard & Howard, Las Vegas Business Press, 
Las Vegas Internet Hospital, 
Lucine Biotechnology,Inc., Maverick Angels, 
Nevada State College, Phoenix Staff, Quantion Advisors, Quertle, SableSystems, Skinvisible Pharmaceuticals, Ubiquita,,
Varian Medical Systems & ViaWest. 

Join researchers, friends, co-workers & supporters of science and technology in Southern Nevada.

NevBio Recognizes Cancer Researchers In Southern Nevada

Nevada Biotechnology & Health Science Consortium
and Lionel Sawyer & Collins 
are pleased to host a Cocktail Party 
Cancer Researchers in Southern Nevada
Saturday, September 28, 2013
6 pm to 10 pm
At the Loft of Mohamed Iqbal, Esq. 
Soho Lofts Unit 807, 900 Las Vegas Boulevard South, Las Vegas, Nevada 89101
No Cost to attend, please RSVP
*Limited Room*

Come join fellow researchers, friends, co-workers & supporters. Please forward this email to others that might want to attend. 

The Nevada Biotechnology & Health Science Consortium wants to recognize those who continue to research treatments for cancer in Southern Nevada and those who have supported, continue to support and/or are interested in cancer research in Southern Nevada. PleaseRSVP.

We are asking researchers to provide an update on their current work in Southern Nevada by giving a brief 5 minute talk at the event (limited spots).

We want to thank our host, Mohamed Iqbal, a litigator with Lionel Sawyer & Collins, whose practice includes international pharmacovigilance and negotiating clinical research agreements. He also addresses IP protection issues, advises start-ups, and has appeared before an FDA Advisory Board in Washington, D.C.

Growing a Life Science industry in Las Vegas is achievable.

Ross Newman will speak at the September 11, 2013 NevBio luncheon. He believes that if a biotech industry is going to be created in Las Vegas it will need: 

1) Commitment - by talented and hardworking people that will ultimately benefit from a biotech industry:
*Experienced Management personnel in pharma/biotech
*Regulatory & Clinical study management
2) Risk Capital & equity man hours 
3) Faith (not hope)

Join us for this discussion on the future of biotechnology in Las Vegas.

Ross Newman, CEO of Innovative Health Research to Speak on the Creation of a Biotech Cluster in Southern Nevada

Ross W. Newman will speak at the NevBio meeting on September 11, 2013. He began his  30+ year career in pharmaceutical/biotech research working as a West Coast correspondent of the investment banking firm Allen & Co. In that role, he directed capital into-and sat on the board of directors of-many early biotech start-ups developed from research coming out of the University of California, San Francisco and Stanford University. As one of the start-ups was failing, he was selected by the board to become the company's new CEO. Newman was just in his 20's when he directed the shut-down and merger into Xoma, Inc. of one of the first monoclonal antibody companies in the country to go into clinical trials and fail. Early in his career, he lost a couple million dollars of his own money (most of which was borrowed, he says) and close to $20 million of investor money. It took until 1996 to pay off his debt. Newman earned a BA in Political Demography from the University of California, Berkeley in 1971. After graduating, he traveled. In 1973, he returned to Berkeley where he completed his doctoral dissertation in epistemology in 1977.